Targeting epigenetic dependencies of tumor initiating cells from triple negative breast cancer therapies

Targeting epigenetic dependencies of tumor initiating cells from triple negative breast cancer therapies

Dr. Fabio Petrocca
Boston Children’s Hospital
Wed, 10/23/2013 - 4:00pm

221 Integrated Sciences Building

Notes: 

Refreshments at 3:45pm